Sarepta Therapeutics (LTS:0L35) Research & Development : $800 Mil (TTM As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Sarepta Therapeutics Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Sarepta Therapeutics's Research & Development for the three months ended in Sep. 2024 was $224 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was $800 Mil.

Sarepta Therapeutics Research & Development Historical Data

The historical data trend for Sarepta Therapeutics's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sarepta Therapeutics Research & Development Chart

Sarepta Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Research & Development

Get a 7-Day Free Trial

560.91

722.34

771.18

877.09

877.39

Sarepta Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Research & Development	Get a 7-Day Free Trial															194.30	195.52	200.40	179.69	224.48

Sarepta Therapeutics Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $800 Mil.

Sarepta Therapeutics (LTS:0L35) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Sarepta Therapeutics Research & Development Related Terms

Thank you for viewing the detailed overview of Sarepta Therapeutics's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Sarepta Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sarepta Therapeutics Inc (LTS:0L35) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

SRPT:USA AB3A:Germany AB3A:Germany S1RP34:Brazil

Address

215 First Street, Suite 415, Cambridge, MA, USA, 02142

Website

https://www.sarepta.com

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of company's product candidates are at an early stage of development.

Sarepta Therapeutics Headlines

No Headlines